Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era-Reference-Cited by-同舟云学术

Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era

Published:2022-07 Issue:7 Volume:28 Page:376-389
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Shimada Hiroyuki^ORCID,Tanizawa Akihiko^ORCID,Kondo Takeshi,Nagamura-Inoue Tokiko^ORCID,Yasui Masahiro,Tojo Arinobu,Muramatsu Hideki,Eto Tetsuya,Doki Noriko,Tanaka Masatsugu^ORCID,Sato Maho,Noguchi Maiko,Uchida Naoyuki,Takahashi Yoshiyuki,Sakata Naoki^ORCID,Ichinohe Tatsuo^ORCID,Hashii Yoshiko,Kato Koji,Atsuta Yoshiko^ORCID,Ohashi Kazuteru

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference48 articles.

1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

2. Chronic myeloid leukemia in children;Hijiya;Pediatr Clin North Am,2015

3. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial;Saussele;Lancet Oncol,2018

4. Discontinuation of imatinib in children with chronic myeloid leukemia: a study from the international registry of childhood cml;Millot;Cancers,2021

5. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC);Millot;Bone Marrow Transplant,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Molecular or Cytogenetic Response as a Favorable Prognostic Factor Before Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia;Transplantation and Cellular Therapy;2024-06

2. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

3. Prognostic factors and predictive scores for 6-months mortality of hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit;Frontiers in Oncology;2023-09-21

4. Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era;American Journal of Hematology;2023-05-12

5. When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?;Transplantation and Cellular Therapy;2022-07